脱フコシル化モノクローナル抗体
↑ “Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies”. Expert Opin Biol Ther 6 (11): 1161–73. (2006). doi:10.1517/14712598.6.11.1161. PMID 17049014.
↑ “Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity”. Nat. Biotechnol. 17 (2): 176–80. (February 17, 1999). doi:10.1038/6179. PMID 10052355.
↑ “Roche - Roche acquires Swiss based GlycArt Biotechnology to strengthen expertise in therapeutic antibody research”. roche.com. 2015年2月5日時点のオリジナルよりアーカイブ。2015年4月29日閲覧。
↑ Presentation: GlycArt Biotechnology AG From Inception to trade sale – and what happened after... by Dr. Joël Jean-Mairet. Brussels, March 31, 2011
↑ “Obinutuzumab: first global approval”.